Cardlytics (CDLX) Tops Q2 EPS by 49c

Cardlytics (NASDAQ: CDLX) reported Q2 EPS of ($0.24), $0.49 better than the analyst estimate of ($0.73). Revenue for the quarter came in at $76.7 million versus the consensus estimate of $69.11 million.

For earnings history and earnings-related data on Cardlytics (CDLX) click here.

You May Also Be Interested In

• Mizuho says ignore Apple noise, flags key catalyst for Micron and memory in H2
• Hormel Foods agrees to sell Brazil's Ceratti brand to Zanchetta
• Hertz Global (HTZ) PT Lowered to $3.50 at Morgan Stanley